Handelsinvest Investeringsforvaltning Ionis Pharmaceuticals Inc Transaction History
Handelsinvest Investeringsforvaltning
- $208 Million
- Q1 2024
A detailed history of Handelsinvest Investeringsforvaltning transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Handelsinvest Investeringsforvaltning holds 5,287 shares of IONS stock, worth $199,901. This represents 0.11% of its overall portfolio holdings.
Number of Shares
5,287
Previous 8,033
34.18%
Holding current value
$199,901
Previous $406,000
43.6%
% of portfolio
0.11%
Previous 0.17%
Shares
2 transactions
Others Institutions Holding IONS
# of Institutions
395Shares Held
125MCall Options Held
2.25MPut Options Held
510K-
Vanguard Group Inc Valley Forge, PA13.8MShares$524 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD12.6MShares$478 Million0.38% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$390 Million0.01% of portfolio
-
Bellevue Group Ag Kuesnacht, V88.26MShares$312 Million6.59% of portfolio
-
Wellington Management Group LLP Boston, MA6.57MShares$248 Million0.06% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $5.37B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...